Approximately 7.6 million individuals in the United States suffer from opioid use disorder (OUD). Three evidence-based medications—methadone, buprenorphine, and naltrexone—are recommended for use by ...

MONMOUTH JUNCTION, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced the acceptance of its peer-reviewed article "The ...

The FDA approved prescription suzetrigine (Journavx) 50 mg oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults, the agency announced Thursday.

Pain management doctors focus on helping a person find relief from pain due to underlying conditions or as long-term consequences of surgical procedures. Pain management doctors work with a variety of ...

Credit: Getty Images. Although the clinical presentation of acute pancreatitis may vary, the most common symptom occurring in 95% of cases is deep epigastric pain that radiates to the back.

The current retrospective chart review found a significant difference in pain management between non-Hispanic/Latino White patients and racial/ethnic minority patients and women. Non-Hispanic/Latino ...

Pain has the potential to affect various aspects of a person’s life, from disrupting one’s daily routine to negatively impacting emotional well-being. It’s also one of the most common reasons that ...

Mercy Family Health announces StemWave acoustic wave therapy for acute and chronic knee pain, offering FDA-listed, ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

Physical activity stimulates the release of endorphins (natural painkillers) and promotes the production of anti-inflammatory ...